Skip to main navigation Skip to search Skip to main content

Design and testing of a health economic Markov model for treatment of anorexia nervosa

  • Vegard G Svendsen*
  • , Joran Lokkerbol
  • , Unna Danner
  • , Alberte Jansingh
  • , Silvia Maa Evers
  • , Ben Fm Wijnen
  • *Corresponding author for this work

Research output: Contribution to journal › Article › Academic › peer-review

Abstract

OBJECTIVES: Anorexia Nervosa (AN) is a severe psychiatric disorder and knowledge about the cost-effectiveness of potential interventions is limited. The aim of this paper is to introduce the Trimbos Institute health economic cost-effectiveness model for Anorexia Nervosa (AnoMod-TI), a flexible modelling tool for assessing the long-term cost-effectiveness of interventions for AN in late adolescent and adult patients, which could support clinical decision making.

METHODS: AnoMod-TI is a state-transition cohort simulation (Markov) model developed from a Dutch societal perspective, which consists of four health states - namely full remission (FR), partial remission (PR), AN and death. Results are expressed as total healthcare costs, QALYs and incremental cost-effectiveness ratio.

RESULTS: For the purpose of demonstrating AnoMod-TI and how it could be used to estimate cost-effectiveness over a 20-year time horizon, it was applied to a hypothetical treatment scenario. Results illustrate how a relatively costly intervention with only modest effects can still be cost-effective in the long term.

CONCLUSIONS: AnoMod -TI can be used to examine long-term cost-effectiveness of various interventions aimed at either treating AN or preventing relapse from a state of partial or full remission. AnoMod-TI is freely available upon request to the authors.

Original languageEnglish
Pages (from-to)1243-1251
Number of pages9
JournalExpert Review of Pharmacoeconomics & Outcomes Research
Volume22
Issue number8
Early online date3 Sept 2022
DOIs
Publication statusPublished - 17 Nov 2022

Fingerprint

Dive into the research topics of 'Design and testing of a health economic Markov model for treatment of anorexia nervosa'. Together they form a unique fingerprint.

Cite this